Skip to content
stoqly

Amkor Technology

AMKR Nasdaq Semiconductors Financials FY2016–FY2025

Amkor Technology's revenue rose 6.2% to $6.7 billion in fiscal 2025. Its operating margin was 7.0%, about the same as 6.9% a year earlier. Free cash flow was $191 million, down 44.6%. It paid out $82 million in dividends and buybacks, 43% of free cash flow. The diluted share count rose 0.3%.

Last close Β· Oct 23, 2026

$39.30

0.6%
Revenue Total sales reported in the income statement.
$6.7B
6.2% vs prior year
Operating margin Operating income as a share of revenue.
7.0%
0.0 pts
Net income Profit after all expenses, interest and tax.
$374M
5.6%
Free cash flow Cash from operations minus capital spending.
$191M
44.7%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
10.4%
0.4 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$9.8B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
22.5x
On $1.75 EPS (TTM)

What Amkor Technology does

No business description yet.

Legal name
AMKOR TECHNOLOGY, INC.
Fiscal year ends
December 31, 2025
Latest annual report
β€”
Accession Β· CIK
0001047127-26-000014
0001047127

Revenue and margins

Amkor Technology had $6.7B of revenue in fiscal 2025, up 6.2% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 8.2% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $191M in fiscal 2025, 2.9% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Amkor Technology returned $82.0M to shareholders in fiscal 2025, 43% of free cash flow. The diluted share count rose 0.3%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Amkor Technology yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of $560M and divides by 248.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 22.5x Β· peers 46.6x Β· sector 33.5x.

Balance sheet

Cash, debt and the ratios that show how comfortably Amkor Technology can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $1.1B$1.2B$1.6B$1.6B$2.0B
Debt incl. finance leases $1.1B$1.2B$1.2B$1.1B$1.4B
Net debt / EBITDA βˆ’0.0xβˆ’0.0xβˆ’0.4xβˆ’0.5xβˆ’0.5x
Debt / equity 0.4x0.3x0.3x0.3x0.3x
Interest coverage 14.8x15.3x8.0x6.8x6.2x
Current ratio 1.7x2.0x2.3x2.1x2.3x
Quick ratio 1.4x1.6x2.0x1.9x2.0x
Total assets $6.0B$6.8B$6.8B$6.9B$8.1B
Total liabilities $3.1B$3.1B$2.8B$2.8B$3.6B
Shareholders' equity $2.9B$3.7B$4.0B$4.1B$4.5B
Net debt (βˆ’ = net cash) βˆ’$9.0Mβˆ’$41.1Mβˆ’$417Mβˆ’$545Mβˆ’$560M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$4.9M

6 insiders

Of sales under plans

32%

$1.6M

DateInsiderTradeSharesPriceValueFiling
Sep 8, 2026 Megan FaustCFO Sold plan 1,000 $49.05 $0.0M Form 4
Aug 17, 2026 Mark N RogersEVP & General Counsel Sold plan 5,000 $59.78 $0.3M Form 4
Aug 11, 2026 Megan FaustCFO Sold plan 1,000 $54.45 $0.1M Form 4
Aug 7, 2026 Douglas A AlexanderDirector Sold plan 5,000 $55.81 $0.3M Form 4
Aug 6, 2026 Guillaume Marie Jean RuttenDirector Sold 25,000 $54.50 $1.4M Form 4
Aug 5, 2026 Guillaume Marie Jean RuttenDirector Sold 25,000 $55.35 $1.4M Form 4
Jul 30, 2026 Kevin K. EngelPresident and CEO, Director Sold 3,221 $47.00 $0.2M Form 4
Jul 16, 2026 Mark N RogersEVP & General Counsel Sold plan 5,000 $65.12 $0.3M Form 4
Jul 14, 2026 Megan FaustCFO Sold plan 1,000 $69.91 $0.1M Form 4
Jun 16, 2026 Mark N RogersEVP & General Counsel Sold plan 5,000 $86.21 $0.4M Form 4
Jun 12, 2026 Winston J ChurchillDirector Sold 5,000 $78.20 $0.4M Form 4
Jun 9, 2026 Megan FaustCFO Sold plan 1,000 $70.30 $0.1M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ• βœ• βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ“ βœ“ βœ•
Current ratio rose βœ“ βœ• βœ“
Share count didn't rise βœ• βœ• βœ•
Gross margin rose βœ• βœ“ βœ•
Revenue rose relative to assets βœ• βœ• βœ“
F-score 5 / 95 / 96 / 9
Accruals ratio βˆ’13.4%βˆ’10.7%βˆ’9.6%
Altman Z'' 4.774.644.49

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Amkor Technology AMKR $9.8B 6.2% 7.0% 2.9% 10.4% 22.5x 6
GlobalFoundries GFS $24.8B 0.6% 11.7% 14.9% 7.1% β€” 8 Compare β†’
ON Semiconductor ON $29.2B βˆ’15.4% 1.4% 23.7% 0.9% 46.6x 5 Compare β†’
Marvell Technology MRVL $210.5B 42.1% 16.1% 17.0% 7.0% 75.4x 6 Compare β†’
First Solar FSLR $18.5B 24.1% 30.6% 22.8% 22.7% 10.6x 7 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $3.9B $4.2B $4.3B $4.1B $5.1B $6.1B $7.1B $6.5B $6.3B $6.7B
Gross profit $710M $761M $711M $649M $901M $1.2B $1.3B $943M $933M $939M
Research and development $117M $167M $157M $138M $141M $166M $149M $178M $163M $167M
Operating income $309M $406M $258M $233M $457M $763M $897M $470M $439M $467M
Interest expense $79.7M $83.8M $78.9M $66.0M $64.2M $51.5M $58.6M $59.0M $64.9M $75.4M
Pretax income $230M $308M $186M $160M $387M $715M $857M $444M $431M $445M
Income tax $51.0M $39.8M $56.2M $37.2M $46.2M $69.5M $89.9M $81.7M $75.5M $68.5M
Net income $176M $264M $127M $121M $338M $643M $766M $360M $354M $374M
Diluted EPS $0.74 $1.10 $0.53 $0.50 $1.40 $2.62 $3.11 $1.46 $1.43 $1.50
Diluted shares 0.24B 0.24B 0.24B 0.24B 0.24B 0.25B 0.25B 0.25B 0.25B 0.25B
Cash flow
Cash from operations $729M $618M $663M $564M $770M $1.1B $1.1B $1.3B $1.1B $1.1B
Capital expenditure $650M $551M $547M $472M $553M $780M $908M $750M $744M $905M
Free cash flow $79.4M $67.3M $116M $91.4M $217M $342M $190M $521M $345M $191M
Depreciation and amortization $555M $582M $572M $524M $510M $564M $613M $632M $595M $642M
Stock-based compensation $3.3M $5.1M $5.0M $6.9M $8.0M $11.0M $13.6M $8.3M $18.4M $20.1M
Acquisitions $0.0M $43.8M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Share buybacks $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Dividends paid $0.0M $0.0M $0.0M $0.0M $0.0M $51.2M $55.1M $74.7M $179M $81.9M
Dividends and buybacks $0.0M $0.0M $0.0M $0.0M $0.0M $51.2M $55.1M $74.7M $179M $82.0M
Balance sheet
Cash and short-term investments $550M $596M $682M $901M $832M $1.1B $1.2B $1.6B $1.6B $2.0B
Total debt $1.4B $1.2B $1.2B $1.3B $1.0B $985M $1.1B $1.1B $923M $1.3B
Finance lease liabilities $0.0M $0.0M $0.0M $23.2M $25.7M $84.3M $111M $106M $178M $149M
Current assets $1.4B $1.6B $1.7B $2.0B $2.1B $2.9B $3.3B $3.2B $3.1B $3.9B
Current liabilities $1.0B $1.3B $1.2B $1.1B $1.3B $1.7B $1.7B $1.4B $1.5B $1.7B
Inventory $268M $214M $231M $221M $297M $485M $630M $393M $311M $438M
Property and equipment, net $2.6B $2.7B $2.7B $2.4B $2.6B $2.9B $3.1B $3.3B $3.6B $3.9B
Total assets $4.1B $4.5B $4.5B $4.7B $5.0B $6.0B $6.8B $6.8B $6.9B $8.1B
Total liabilities $2.7B $2.8B $2.6B $2.7B $2.7B $3.1B $3.1B $2.8B $2.8B $3.6B
Shareholders' equity $1.4B $1.7B $1.8B $2.0B $2.3B $2.9B $3.7B $4.0B $4.1B $4.5B
Margins
Gross margin 18.1% 18.1% 16.5% 16.0% 17.8% 20.0% 18.8% 14.5% 14.8% 14.0%
Operating margin 7.9% 9.6% 6.0% 5.8% 9.1% 12.4% 12.7% 7.2% 6.9% 7.0%
EBITDA margin 22.0% 23.5% 19.2% 18.7% 19.2% 21.6% 21.3% 16.9% 16.4% 16.5%
Net margin 4.5% 6.3% 2.9% 3.0% 6.7% 10.5% 10.8% 5.5% 5.6% 5.6%
FCF margin 2.0% 1.6% 2.7% 2.3% 4.3% 5.6% 2.7% 8.0% 5.5% 2.9%
Returns
Return on capital 11.0% 15.3% 7.6% 7.4% 16.2% 25.0% 24.3% 10.6% 10.0% 10.4%
Return on capital employed 10.1% 12.9% 7.9% 6.7% 12.5% 18.9% 18.9% 8.9% 8.1% 7.9%
Return on equity 13.6% 17.1% 7.2% 6.4% 15.8% 24.4% 23.2% 9.4% 8.7% 8.7%
Return on assets 4.3% 6.1% 2.8% 2.6% 7.0% 11.6% 11.9% 5.3% 5.2% 5.0%
Growth
Revenue growth 36.2% 7.1% 2.6% βˆ’6.1% 24.6% 21.5% 15.5% βˆ’8.3% βˆ’2.9% 6.2%
Net income growth 243.5% 50.2% βˆ’51.8% βˆ’4.9% 179.7% 90.2% 19.1% βˆ’53.0% βˆ’1.6% 5.6%
EPS growth 236.4% 48.7% βˆ’51.8% βˆ’5.7% 180.0% 87.1% 18.7% βˆ’53.1% βˆ’2.1% 4.9%
FCF growth 68.9% βˆ’15.2% 72.7% βˆ’21.4% 137.4% 57.4% βˆ’44.2% 173.3% βˆ’33.7% βˆ’44.7%
Share count change 0.4% 0.7% 0.0% 0.2% 0.9% 1.4% 0.2% 0.4% 0.3% 0.3%
Financial health
Net debt / EBITDA 0.9x 0.7x 0.7x 0.6x 0.2x βˆ’0.0x βˆ’0.0x βˆ’0.4x βˆ’0.5x βˆ’0.5x
Debt / equity 1.0x 0.7x 0.7x 0.7x 0.4x 0.4x 0.3x 0.3x 0.3x 0.3x
Interest coverage 3.9x 4.8x 3.3x 3.5x 7.1x 14.8x 15.3x 8.0x 6.8x 6.2x
Current ratio 1.4x 1.3x 1.4x 1.9x 1.6x 1.7x 2.0x 2.3x 2.1x 2.3x
Quick ratio 1.1x 1.1x 1.2x 1.7x 1.4x 1.4x 1.6x 2.0x 1.9x 2.0x
Capital allocation
Capex / revenue 16.6% 13.1% 12.7% 11.7% 11.0% 12.7% 12.8% 11.5% 11.8% 13.5%
Stock comp / revenue 0.1% 0.1% 0.1% 0.2% 0.2% 0.2% 0.2% 0.1% 0.3% 0.3%
Payouts / FCF 0.0% 0.0% 0.0% 0.0% 0.0% 15.0% 28.9% 14.4% 51.8% 42.9%
Quality scores
Piotroski F-score 8.0 7.0 5.0 4.0 7.0 8.0 5.0 5.0 5.0 6.0
Altman Z'' 1.5 1.7 2.0 2.6 3.0 3.8 4.6 4.8 4.6 4.5
Accruals ratio βˆ’13.6% βˆ’8.3% βˆ’11.9% βˆ’9.6% βˆ’8.9% βˆ’8.7% βˆ’5.2% βˆ’13.4% βˆ’10.7% βˆ’9.6%

Source: SEC EDGAR XBRL filings (CIK 0001047127). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open